SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea
Closed for comments This consultation ended on at Request commenting lead permission
5 Recommendations for further research
5.1 Further research is recommended to understand how SeHCAT test results affect clinical decision making.
5.2 Further research is recommended to assess clinical outcomes after positive and negative SeHCAT test results. This research should focus on clinical outcomes relevant to people with chronic diarrhoea, such as severity of symptoms. Clinical outcomes should be measured in the short and long term.
5.3 Further research is recommended to assess the effectiveness of treatment options for bile acid diarrhoea. Consideration should be given to how well the treatments are tolerated and how they affect the severity of symptoms in the longer term.
5.4 Further research is recommended to better understand the health-related quality of life in people with bile acid diarrhoea. Consideration should be given to how quality of life differs before and after diagnosis, and how it is affected by treatment and symptom severity.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions